Marked and sustained improvement two years after autologous stem cell transplantation in a girl with systemic sclerosis.

Autologous transplantation of hematopoietic stem cells has recently been proposed as a possible treatment for autoimmune diseases that are associated with a very severe prognosis. A 12-year-old girl who, since 4 years of age, had systemic sclerosis with progressive pulmonary involvement underwent autologous peripheral blood-derived stem cell transplantation (aPBSCT) using CD34+ selection, cyclophosphamide, and the infusion of the monoclonal antibody CAMPATH-1G. Following transplantation, in the absence of any treatment other than symptomatic therapy, the patient's exertional dyspnea and alveolitis disappeared and she experienced a marked improvement in skin score, height velocity, and general well-being that has persisted 2 years after the transplantation procedure. Autologous PBSCT associated with the infusion of the monoclonal antibody CAMPATH-1G appears to be a useful therapy for otherwise intractable forms of progressive systemic sclerosis.

[1]  R. Ramsey‐Goldman,et al.  Hematopoietic stem-cell transplantation for systemic lupus erythematosus. , 1997, The New England journal of medicine.

[2]  A. Anagnostopoulos,et al.  Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study , 1997, Bone Marrow Transplantation.

[3]  D. Joske.  Autologous bone-marrow transplantation for rheumatoid arthritis , 1997, The Lancet.

[4]  A. Bacigalupo,et al.  Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration , 1997, Lupus.

[5]  M. Vignetti,et al.  Blast crisis of chronic myelogenous leukemia in long-lasting systemic lupus erythematosus: regression of both diseases after autologous bone marrow transplantation. , 1997, Blood.

[6]  J. Snowden,et al.  Prolonged remission of longstanding systemic lupus erythematosus after autologous bone marrow transplant for non-Hodgkin’s lymphoma , 1997, Bone Marrow Transplantation.

[7]  Furst De,et al.  Choosing appropriate patients with systemic sclerosis for treatment by autologous stem cell transplantation. , 1997 .

[8]  A. Gratwohl,et al.  Blood and marrow stem cell transplants in autoimmune disease. A consensus report written on behalf of the European League Against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT). , 1997, British journal of rheumatology.

[9]  Seah H. Lim,et al.  Peripheral blood stem-cell transplantation for refractory autoimmune thrombocytopenic purpura , 1997, The Lancet.

[10]  A. Goldstone,et al.  Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: a new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data. Lymphoma Working Party of the European Group for Blood and Marrow T , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  J. Winkler,et al.  Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantation , 1997, The Lancet.

[12]  N. Schmitz,et al.  Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation. , 1996, Blood.

[13]  A. Gratwohl,et al.  Autologous haemopoietic stem cell transplantation in a patient with severe pulmonary hypertension complicating connective tissue disease. , 1996 .

[14]  B. Hazleman,et al.  Monoclonal antibody therapy of diffuse cutaneous scleroderma with CAMPATH-1H. , 1996, The Journal of rheumatology.

[15]  M. Gattinara,et al.  Validation of the Italian version of the Stanford Childhood Health Assessment Questionnaire for measuring functional status in children with chronic arthritis. , 1995, Clinical and experimental rheumatology.

[16]  A. Marmont,et al.  Stem cell transplantation for severe autoimmune diseases: new proposals but still unanswered questions. , 1995, Bone marrow transplantation.

[17]  J. Lynch,et al.  Immunosuppressive treatment of the pulmonary manifestations of progressive systemic sclerosis. , 1995, Current opinion in rheumatology.

[18]  P. Lachenbruch,et al.  Immunosuppression with chlorambucil, versus placebo, for scleroderma. Results of a three-year, parallel, randomized, double-blind study. , 1989, Arthritis and rheumatism.

[19]  James M. Tanner,et al.  Growth at Adolescence , 1956 .